2-[N-(9-Fluorenylmethoxycarbonyl)-N-decylamino]ethanal

CAS: 239088-22-3

Ref. 3D-FF23341

Produktinformation

• Name: 2-[N-(9-Fluorenylmethoxycarbonyl)-N-decylamino]ethanal
• Synonyme: N-Decyl-N-(2-oxoethyl)-9H-fluoren-9-ylmethyl esterDecyl(2-oxoethyl)-carbamic acid 9H-fluoren-9-ylmethyl ester, (9H-Fluoren-9-yl)methyl decyl(2-oxoethyl)carbamate, (9H-Fluoren-9-yl)methyldecyl(2-oxoethyl)carbamate, 9H-Fluoren-9-ylmethyl N-decyl-N-(2-oxoethyl)carbamate, Carbamic acid, decyl(2-oxoethyl)-, 9H-fluoren-9-ylmethyl ester, carbamic acid, N-decyl-N-(2-oxoethyl)-, 9H-fluoren-9-ylmethyl ester

Beschreibung

Telavancin is a novel lipoglycopeptide antibiotic that inhibits bacterial cell wall synthesis. It has been shown to be effective against methicillin-resistant Staphylococcus aureus (MRSA) and Clostridium perfringens, although is not active against acid-fast bacteria such as Mycobacterium tuberculosis or Mycobacterium avium complex. Telavancin binds to the peptidoglycan layer of the bacterial cell wall by competitive inhibition. This binding prevents the formation of an antibiotic-inhibitor complex with the enzyme cell wall synthesis that is required for cell wall biosynthesis, inhibiting protein synthesis and cell division. Telavancin also inhibits the production of bacterial exotoxins and DNA gyrase, which is responsible for maintaining the integrity of bacterial DNA. The hydrolysis of telavancin in vivo occurs by amination followed by acetal cleavage to yield 2-[N-(9-flu

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 421.57 g/mol
• Formel: C₂₇H₃₅NO₃
• Reinheit: Min. 95%